Fresenius/€FRE

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Fresenius

Fresenius SE & Co. KGaA, operating under the ticker FRE, is a global healthcare group founded in 1912. The company specializes in products and services for dialysis, hospitals, and outpatient medical care. Operating in the healthcare sector, Fresenius provides a range of services including engineering and services for hospitals and other healthcare facilities.

Ticker

€FRE

Primary listing

XETRA

Industry

Health Care Providers & Services

Employees

175,202

ISIN

DE0005785604

Fresenius Metrics

BasicAdvanced
€23B
55.45
€0.75
0.94
€1.00
2.40%

What the Analysts think about Fresenius

Analyst ratings (Buy, Hold, Sell) for Fresenius stock.

Bulls say / Bears say

Fresenius reported a 13% increase in fourth-quarter operating earnings, surpassing expectations, and achieved significant cost savings for 2023, leading to a share price rise of over 4%. (reuters.com)
The company exceeded second-quarter profit expectations due to strong performances by its Kabi and Helios units and successful cost-saving measures, with earnings before interest and taxes rising to €660 million, a 16% increase from the previous year. (reuters.com)
Fresenius raised its 2025 structural savings target to €400 million from €350 million, indicating a strong commitment to cost efficiency and profitability. (reuters.com)
Investors are seeking more transparency from Fresenius regarding its strategy and timeline for reducing control over its dialysis division, Fresenius Medical Care, which continues to deter potential shareholders. (reuters.com)
Fresenius Medical Care's shares fell as much as 9% after reporting second-quarter revenue that missed estimates due to underwhelming U.S. patient-care volume growth. (bloomberg.com)
Despite strong quarterly results, Fresenius Medical Care's shares fell 5% due to concerns over weak patient volume projections, with the company targeting slower growth compared to competitors. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.

Fresenius Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Fresenius Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €FRE

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs